Hatha yoga |
|
|
Clinical Trial: Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| HIV Infections Diabetes Depression | Behavior: Yoga | Phase I |
MedlinePlus related topics: AIDS; Depression; Diabetes
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Yoga, Health, and Meditation
Expected Total Enrollment: 50
Study start: July 2004
In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.
Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.
Eligibility
Ages Eligible for Study: 14 Years - 40 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria for Study 1 Participants:
- Meet certain laboratory requirements
Inclusion Criteria for Study 2 Participants:
- HIV infected
- Able to walk at least 50% of the time
Inclusion Criteria for All Participants:
- Written informed consent of parent/guardian, if applicable
Exclusion Criteria for Study 2 Participants:
- Require antiretroviral therapy
Location Information
Frederick M. Hecht, MD, Principal Investigator, UCSF Positive Health Program
More Information
Record last reviewed: January 2005
Last Updated: January 24, 2005
Record first received: August 26, 2004
ClinicalTrials.gov Identifier: NCT00090506
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


